GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » Change In Payables And Accrued Expense

JFL Life Sciences (NSE:JFLLIFE) Change In Payables And Accrued Expense : ₹0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is JFL Life Sciences Change In Payables And Accrued Expense?

JFL Life Sciences's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ₹0.0 Mil. It means JFL Life Sciences's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

JFL Life Sciences's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was ₹0.0 Mil. It means JFL Life Sciences's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .

JFL Life Sciences Change In Payables And Accrued Expense Historical Data

The historical data trend for JFL Life Sciences's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JFL Life Sciences Change In Payables And Accrued Expense Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Payables And Accrued Expense Get a 7-Day Free Trial - - - - -

JFL Life Sciences Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JFL Life Sciences Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of JFL Life Sciences's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

JFL Life Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JFL Life Sciences Ltd (NSE:JFLLIFE) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
BOM:524711 BOM:542248 BOM:524703 BOM:530317 BOM:524396 BOM:524652 BOM:543963 BOM:540702 BOM:542934 BOM:537253 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
Website
https://www.jfllifesciences.com
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.

JFL Life Sciences Headlines

No Headlines